FDA wants heartburn drug pulled from market

The Food and Drug Administration is asking all makers of ranitidine, a heartburn drug most commonly known by the brand name Zantac, to pull all forms of the medicine from the market.

The bottom line: Don't take any versions of this drug, which has been linked to cancer-causing contaminants.